Parexel Los Angeles Early Phase Clinical Unit is a clinical research site located in Glendale, California, United States 91206.
Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.
Parexel Los Angeles Early Phase Clinical Unit has participated in 3 clinical trials.
Therapeutic areas: Cognitive Dysfunction, Schizophrenia, Alcohol Use Disorder.
Sponsors: Kynexis B.V., Dicerna Pharmaceuticals, Inc., a Novo Nordisk company.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in Glendale
Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Parexel Los Angeles Early Phase Clinical Unit has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Parexel Los Angeles Early Phase Clinical Unit has 3 clinical trials on record. Their work covers Cognitive Dysfunction, Schizophrenia, Alcohol Use Disorder.
Parexel Los Angeles Early Phase Clinical Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.